-
1 Comment
AK Medical Holdings Limited is currently in a long term downtrend where the price is trading 8.5% below its 200 day moving average.
From a valuation standpoint, the stock is 91.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.2.
AK Medical Holdings Limited's total revenue rose by 13.8% to $556M since the same quarter in the previous year.
Its net income has increased by 10.0% to $151M since the same quarter in the previous year.
Finally, its free cash flow grew by 187.8% to $73M since the same quarter in the previous year.
Based on the above factors, AK Medical Holdings Limited gets an overall score of 4/5.
| ISIN | KYG020141019 |
|---|---|
| Sector | Healthcare |
| Industry | Medical Devices |
| Exchange | HK |
| CurrencyCode | HKD |
| Target Price | 7.1258 |
|---|---|
| Dividend Yield | 1.2% |
| Market Cap | 7B |
| PE Ratio | 23.6 |
| Beta | -0.5 |
AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products in China and internationally. It offers knee, hip, and spinal and trauma replacement implants; and 3D-printed products, such as 3D-printed hip and knee replacement implants, 3D-printed spinal and trauma implants, and customised products and services. The company also distributes third party orthopedic products; and offers surgical instruments and medical irrigators. Its principal customers include distributors, hospitals, physicians and surgeons, and patients. The company was founded in 2003 and is headquartered in Beijing, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1789.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
